Tracking when private companies are nearing a sale, recap, or financing event has always been a guessing game. With thousands of sponsor-backed firms spread across sectors and geographies, most deal teams are forced to react after the market moves.
Investors, bankers, and service providers struggle to know which private companies are gearing up for a transaction or capital raise. Signals are scattered, opaque, and nearly impossible to track across thousands of PE- and VC-backed businesses.
Dakota centralizes those signals (holding periods, funding rounds, platform acquisition dates, ownership changes, and exit timing patterns) into one predictive transaction-readiness tool. Instead of waiting for headlines, users can see which companies are showing the strongest likelihood of pursuing a sale, recapitalization, or new financing before the market knows.
Below is today’s list of five PE- or VC-backed companies that, based on their hold period, financing stage, and last transaction date, appear to be credible candidates for a sale or next-round raise.
Nothing is guaranteed, but these companies fall squarely within the timing windows where sponsors typically look to generate liquidity or secure additional capital.
Sourced from Dakota Sponsor Backed Companies.
1. Remos Space Systems AB
Remos Space Systems AB is a Gothenburg-based aerospace company founded in 2015 that develops and manufactures small satellite platforms, propulsion systems, and payload integration solutions. The company serves commercial and government customers with satellite systems designed for cost-effective and reliable space missions.
- Sector: Aerospace / Space Technology
- Last known transaction date: Seed, €1M (March 2025)
- Why timing suggests a near-term transaction: Remos Space Systems AB’s $1.09M seed round announced in March 2025 places the company approximately 12–18 months removed from its initial financing by mid to late 2026, consistent with the typical window when seed-stage companies begin planning their next raise. As technology validation, pilot deployments, and aerospace partnerships progress, the company is likely to evaluate follow-on capital, strategic defense investment, or early acquisition interest.
View all private company data in Dakota Marketplace.
2. Arcade
Arcade is an AI-driven product creation platform that enables users to design and customize consumer goods through generative tools. The platform converts user-generated designs into physical products manufactured by third-party artisans.
- Sector: Generative AI / Consumer Commerce Infrastructure
- Last known transaction date: Series A, $25M, March 2025
- Why timing suggests a near-term transaction: Arcade’s $25M Series A announced in March 2025 places the company roughly 12–18 months removed from its most recent financing by mid to late 2026, consistent with the typical timing for Series A companies preparing for their next growth round. As product adoption, revenue traction, and strategic partnerships expand, the company is likely to evaluate follow-on capital, strategic investment, or acquisition interest.
View all private company data in Dakota Marketplace.
3. Neuranics
Neuranics is a deep-tech startup specializing in magnetic sensing solutions for healthcare, gaming, and metaverse applications. Founded in 2021 as a spinout from the Universities of Glasgow and Edinburgh, the company focuses on developing Tunneling Magnetoresistance (TMR) quantum sensing technologies. Their product offerings include TMR sensors, custom integrated circuits (ASICs), and AI-enabled hardware and software solutions. Neuranics aims to revolutionize human-machine interfaces by providing ultra-sensitive, low-power, and scalable magnetic sensors that detect tiny magnetic signals from the human body, enabling precise tracking of muscle activity for gesture recognition and heart signals without skin contact.
- Sector: Semiconductor / Deep Tech (Magnetic Sensing & Human-Machine Interface)
- Last known funding round: $8M funding round, April 2025
- Why timing suggests a near-term transaction: Neuranics’ $8M round announced in April 2025 positions the company approximately 12–18 months from its latest financing window by mid-to-late 2026, consistent with early-stage deep tech hardware companies advancing toward commercial deployment. As Neuranics scales development of its ultra-sensitive magnetic sensing technology for next-generation human-machine interfaces, spanning wearables, XR, consumer electronics, and industrial applications, the company will likely require follow-on capital to expand engineering, secure design wins with OEMs, and transition from prototyping to volume production. Given the strategic importance of advanced sensing in spatial computing and edge devices, a Series A or strategic investment from semiconductor, consumer electronics, or AR/VR ecosystem players could emerge as commercialization milestones are achieved.
View all private company data in Dakota Marketplace.
4. InfiniLink
InfiniLink is a Cairo-based semiconductor company that develops high-speed connectivity solutions for AI data centers, including SerDes and optical transceiver chiplets built on silicon and silicon photonics technologies. Its products include optical transceiver engines designed for low-power Ethernet and PCIe linear pluggable optical modules.
- Sector: Industrials
- Last known funding round: Seed, $10M, March 2025
- Why timing suggests a near-term transaction: InfiniLink’s $10M seed round announced in March 2025 places the company approximately 12–18 months removed from its initial financing by mid to late 2026, consistent with the typical window when seed-stage semiconductor startups begin preparing for their next raise. As product development advances and partnerships within the AI data center ecosystem expand, the company is likely to evaluate follow-on capital, strategic semiconductor investment, or acquisition interest.
View all private company data in Dakota Marketplace.
5. Signadori Bio
Signadori Bio is a Paris-based biotechnology company founded in 2025 that develops next-generation cellular immunotherapies for cancer treatment. The company is in the early stages of development, focused on advancing cell and gene therapy programs through research and initial clinical validation.
- Sector: Biotechnology (Cell & Gene Therapy / Oncology)
- Last known funding round: Seed, March 2025
- Why timing suggests a near-term transaction: Signadori Bio’s seed round announced in March 2025 places the company approximately 12–18 months removed from its initial institutional financing by mid to late 2026, aligning with the typical window when seed-stage biotech companies begin preparing for a follow-on raise. As preclinical milestones and platform validation advance, the company is likely to evaluate additional growth capital, strategic partnerships, or early acquisition interest.
View all private company data in Dakota Marketplace.
Use Dakota’s Sponsor Backed Company Intelligence to Spot Likely Exits Before the Market Does
Dakota’s private company data gives you a real-time view into thousands of sponsor-backed companies, including platform acquisition dates, funding rounds, parent sponsors, add-on activity, and sector categorization.
Instead of guessing where companies are in their lifecycle, you can instantly identify which ones are approaching the typical timing windows for a sale or recap.
Fully integrated into Dakota Marketplace, this dataset enables deal sourcers, investor relations teams, and allocators to anticipate transactions, build targeted outreach lists, and stay ahead of market announcements, every single day.
To explore more companies likely to transact, book a demo of Dakota Marketplace!
